产品描述: ASP3026 has been used in trials studying the treatment of Solid Tumor, B-Cell Lymphoma, Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, and Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS. |
靶点:
ALK;Apoptosis;Apoptosis;ALK |
体内研究:
ASP3026抑制内源性表达EML4-ALK变体3的人NSCLC肿瘤细胞系NCI-H2228的生长,IC50值为64.8 nM。ASP3026在酪氨酸激酶中比PF02341066显示更强的选择性抑制ALK活性 |
参考文献:
1.Sadao Kuromitsu, et al. AACR 102nd Annual Meeting, 2011. |
溶解性:
DMSO:11.6 mg/mL (20 mM) |
保存条件:
-20℃ |
配置溶液浓度参考:
|
1mg |
5mg |
10mg |
1 mM |
1.722 ml |
8.61 ml |
17.219 ml |
5 mM |
0.344 ml |
1.722 ml |
3.444 ml |
10 mM |
0.172 ml |
0.861 ml |
1.722 ml |
50 mM |
0.034 ml |
0.172 ml |
0.344 ml |
|
注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |